Correlation Between ChemoMetec A/S and Talanx AG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ChemoMetec A/S and Talanx AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ChemoMetec A/S and Talanx AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ChemoMetec AS and Talanx AG, you can compare the effects of market volatilities on ChemoMetec A/S and Talanx AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ChemoMetec A/S with a short position of Talanx AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of ChemoMetec A/S and Talanx AG.

Diversification Opportunities for ChemoMetec A/S and Talanx AG

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between ChemoMetec and Talanx is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding ChemoMetec AS and Talanx AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talanx AG and ChemoMetec A/S is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ChemoMetec AS are associated (or correlated) with Talanx AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talanx AG has no effect on the direction of ChemoMetec A/S i.e., ChemoMetec A/S and Talanx AG go up and down completely randomly.

Pair Corralation between ChemoMetec A/S and Talanx AG

Assuming the 90 days horizon ChemoMetec A/S is expected to generate 1.53 times less return on investment than Talanx AG. In addition to that, ChemoMetec A/S is 2.02 times more volatile than Talanx AG. It trades about 0.07 of its total potential returns per unit of risk. Talanx AG is currently generating about 0.22 per unit of volatility. If you would invest  8,080  in Talanx AG on December 22, 2024 and sell it today you would earn a total of  1,510  from holding Talanx AG or generate 18.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ChemoMetec AS  vs.  Talanx AG

 Performance 
       Timeline  
ChemoMetec A/S 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ChemoMetec AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ChemoMetec A/S may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Talanx AG 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Talanx AG are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Talanx AG reported solid returns over the last few months and may actually be approaching a breakup point.

ChemoMetec A/S and Talanx AG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ChemoMetec A/S and Talanx AG

The main advantage of trading using opposite ChemoMetec A/S and Talanx AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ChemoMetec A/S position performs unexpectedly, Talanx AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talanx AG will offset losses from the drop in Talanx AG's long position.
The idea behind ChemoMetec AS and Talanx AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEOs Directory
Screen CEOs from public companies around the world